BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Abliva - ECPv6.15.14//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Abliva
X-ORIGINAL-URL:https://abliva.com
X-WR-CALDESC:Events for Abliva
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/Stockholm
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20210328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20211031T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20220327T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20221030T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20230326T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20231029T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20221007
DTEND;VALUE=DATE:20221009
DTSTAMP:20260407T162048
CREATED:20220816T123412Z
LAST-MODIFIED:20221004T113151Z
UID:3313-1665100800-1665273599@abliva.com
SUMMARY:Mitocon's Mitochondrial Diseases Conference
DESCRIPTION:In October\, Abliva will attend the Italian patient organization Mitocon’s annual Mitochondrial Diseases Conference in Rome\, Italy. \nOn October 8\, Abliva’s Chief Medical Officer Magnus Hansson will give the talk: An adaptive\, clinical Phase 2/3 study evaluating the efficacy of KL1333 in adult primary mitochondrial disease patients in Session 5: Challenges and pitfalls in clinical trials design – presentations and round table discussion.
URL:https://abliva.com/event/mitocons-mitochondrial-diseases-conference/
LOCATION:Holiday Inn Rome EUR Parco dei Medici\, Rome\, Italy
CATEGORIES:Scientific event
ATTACH;FMTTYPE=image/jpeg:https://abliva.com/wp-content/uploads/2022/08/Rome_Colosseo.jpeg
END:VEVENT
END:VCALENDAR